A drug developed over half a century ago to treat malaria is showing signs that it may also help cure COVID-19 -- especially when combined with an antibiotic, a promising new study reveals.

In the wake of the coronavirus outbreak, Dr. Manny Alvarez said on Friday that he is “bullish” on the anti-malaria drug Chloroquine protocol because the preliminary results have shown that it ...

The majority of all cases (94%) and malaria-related fatalities (95%) occurred in Africa, and children aged under five accounted for three-quarters of all deaths.

The anti-malarial drug Artemisinin is highly effective. It's critical for kids, who are especially vulnerable. A new study comes to an alarming conclusion.

For now the drug remains effective in most cases, and second-line treatments -- albeit less potent -- ensure deaths are still relatively rare in Thailand, which reported about 30,000 cases and 12 ...

After six days, he said, only 25 percent of patients who took this drug still had the virus in their body. By contrast, 90 percent of those who had not taken hydroxychloroquine continued to carry ...

The search for new ways to treat malaria — a disease that kills some 600,000 people a year, most of them children in Sub-Saharan Africa — may have just gotten a boost. Chemists at UC San Francisco ...

A new study finds no evidence of benefit from a malaria drug widely promoted as a treatment for coronavirus infection. Hydroxychloroquine did not lower the risk of dying or needing a breathing ...

Drug resistance is inevitable — the more a treatment is used, the faster resistance will often develop, and the fact is that there are some 250 million cases of malaria a year.

Researchers from the Wellcome Sanger Institute and University of Ghana were able to demonstrate for the first time that end-to-end, real-time pathogen monitoring from clinical blood samples is ...